Clinical trials
Acromegaly trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Terminated | 11 |
| Unknown status | 5 |
| Recruiting | 4 |
| Approved for marketing | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cedars-Sinai Medical Center | 9 |
| Ipsen | 7 |
| Novartis Pharmaceuticals | 7 |
| Crinetics Pharmaceuticals Inc. | 5 |
| Columbia University | 4 |
| Massachusetts General Hospital | 4 |
| Chiasma, Inc. | 3 |
| Ionis Pharmaceuticals, Inc. | 3 |
| Camurus AB | 2 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acromegaly | 64 |
| Pituitary Neoplasms | 8 |
| Pituitary Diseases | 5 |
| Gigantism | 3 |
| Pituitary ACTH Hypersecretion | 3 |
| Prolactinoma | 3 |
| Adenoma | 2 |
| Dwarfism, Pituitary | 2 |
| Neoplasms | 2 |
| Adrenocortical Hyperfunction | 1 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.